Alkermes PLC (ALKS) Stock Price, Quote, News & History

ALKSNASDAQ
$33.38
-0.33-0.98%
At close: May 1, 5:00 PM EST
$33.38
N/A
After Hours: 4:00 PM EST
Earnings: Q1 2026 Earnings in 4 days from now on Tue May 5th, before the market open
Conference Call: Conference call scheduled in 4 days at 8:00 AM
Click to view the webcast
20%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
520.75M
Investing Cash Flow (TTM)
295.50M
Financing Cash Flow (TTM)
12.38M
Free Cash Flow (TTM)
480.33M
Capital Expenditure (TTM)
-40.42M
Net Change in Cash (TTM)
828.63M

Analyst Trends and Forecast

5
Nov 25
3
1
Feb
1
Mar
1
Apr
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$5.09B
PE Ratio (TTM)
23.57
PE Ratio (FWD)
147.06
PEG Ratio (TTM)
-
PS Ratio (TTM)
3.85
PB Ratio (TTM)
3.08
Earnings Yield % (TTM)
4.24%
Earnings Yield % (FWD)
0.68%
EV / EBITDA (TTM)
15.37
Price / EBITDA (TTM)
17.19
Price / Free Cash Flow (TTM)
11.84
Book Value / Share
$10.94

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
$0
Total Cash
$388.57M
Debt to Equity
0.04
Issuance of Debt (TTM)
$0
Repayment of Debt (TTM)
$0

Key Statistics

Open
$33.42
Close
$33.38
Volume / Avg.
1.19M / 2.24M
Day Range
$33.12 - $33.90
52 Wk Range
25.17 - 36.48
Market Cap
$5.51B
P/E Ratio
23.57
Dividend Yield
-
Exchange
NASDAQ
RSI
52
Short Interest
17.29%
Days to Cover
8.17

About

Sector
Health Care
Industry
Biotechnology
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to ...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Alkermes (ALKS) stock?

A

You can purchase shares of Alkermes (NASDAQ:ALKS) through any online brokerage.

View our list of the best stock brokerages

Q

What is the forecast, or price target, for Alkermes (ALKS) stock?

A

Alkermes has a consensus price target of $42.26.

Q

What is the current price for Alkermes (ALKS)?

A

The stock price for Alkermes (NASDAQ: ALKS) is $33.38 last updated May 1, 2026 at 4:00 PM EDT.

Q

Does Alkermes (ALKS) pay a dividend?

A

There are no upcoming dividends for Alkermes.

Q

When is Alkermes (NASDAQ:ALKS) reporting earnings?

A

Alkermes does not have any upcoming earnings scheduled.

Q

Is Alkermes (ALKS) going to split?

A

There is no upcoming split for Alkermes.

Q

What sector and industry does Alkermes (ALKS) operate in?

A

Alkermes is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.